Skip to main content

News & Press Releases

Filter by:

News Thumbnail Mintz

CRE Daily quoted Member Jeffrey Moerdler in an article about how investors are increasingly seeking new builds rather than acquisitions of older data centers as AI-driven demand continues. Some industry leaders suggest that this trend may be overlooking the opportunities offered by existing assets.

News Thumbnail Mintz

Member Marguerite McConihe was quoted by 9fin in an article about the opportunities and risks associated with the use of AI technologies in leveraged finance. The article notes that while LevFin bankers have largely benefitted from AI, questions are emerging around credit risk, cyber security vulnerabilities, and treating AI-generated assets or IP as debt collateral.

News Thumbnail Mintz

Agenda quoted Member Jacob Hupart in a recent article about the strategic questions audit committee members might consider asking their CFOs. The article notes the importance of monitoring key risks and opportunities, including ESG compliance and strategy, cybersecurity, data governance, and AI use.

News Thumbnail Mintz

In a recent Agenda article, Member Jennifer Rubin shared insights about security and emergency planning for companies facing high-risk incidents. Following the tragic shooting at a Manhattan office building in late July, the piece explores how companies can communicate effectively with investors, maintain strong oversight, and protect employees amid growing concerns about workplace safety.

News Thumbnail Mintz

At Bisnow’s DICE: South event in Dallas this month, Member Jeffrey Moerdler participated in a discussion with other industry leaders about how investors may be overlooking data center acquisitions. Bisnow quoted Jeffrey in a recent article about the takeaways from the event.

News Thumbnail Mintz

Member Theresa Carnegie connected with Endpoints News about the pharmaceutical industry's continued legal challenges to the Inflation Reduction Act, even as the federal government has prevailed in about a dozen cases so far. AstraZeneca, one of the companies still pushing back, recently requested more time to petition the Supreme Court following a loss in the Third Circuit.

Alex Harris
Press Contact

Alexandra Harris

Public Relations Manager

[email protected]
|
1.212.692.6816

Follow Mintz